<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2078">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079830</url>
  </required_header>
  <id_info>
    <org_study_id>KVIT2016</org_study_id>
    <nct_id>NCT03079830</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery</brief_title>
  <acronym>PPMAMIAVS</acronym>
  <official_title>Efficacy of Ropivacaine Wound Infiltration for Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the efficacy of local anesthestic application through the catheter in
      the surgical wound for the postoperative pain relief after minimally invasive aortic valve
      surgery. The patients will be enrolled in the three different groups according to the
      protocol of the local anesthetic and saline administration:

        1. group: continous infusion of the local anesthetic plus bolus on demand

        2. group: bolus of local anesthetic on demand

        3. group: continous infusion of saline plus bolus on demand For all patients metamizol
           every 12 hours plus bolous of piritramid on demand.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing minimally invasive aortic valve replacment surgery will be enroled in
      the study, after giving a signed informed consent.

      The study evaluates the efficacy of local anesthestic application through the catheter in
      the surgical wound for the postoperative pain relief after minimally invasive aortic valve
      surgery.

      Patients will then be randomised in three groups according to the protocol:

        1. group: continous infusion of the local anesthetic plus bolus on demand

        2. group: bolus of local anesthetic on demand

        3. group: continous infusion of saline plus bolus on demand All patients will receive
           Metamizol every 12 hours plus bolus of piritramid on demand.

      Analgesia effectivness will be checked hourly according to the visual analogue scale (VAS).
      According to protocol, bolus will be given every time the score of VAS scale is &gt;3.

      The catheter will be removed 48 hours after the protocols' start.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of daily cumulative postoperative dose of Piritramid between the three different protocols, using VAS scale to determine level of analgesia.</measure>
    <time_frame>48 hours after admission to the intensive care unit (ICU)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications related to the catheter in the surgical wound</measure>
    <time_frame>72 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale (VAS)</measure>
    <time_frame>48 hours after admission to the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the effectivness between the two protocols of continous and bolus administration of local anesthetic, using VAS scale to determine level of analgesia.</measure>
    <time_frame>48 hours after admission to the ICU</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Aortic Valve Surgery</condition>
  <condition>Postoperative; Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine continous infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Piritramid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine bolus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Piritramid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline continous</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Piritramid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piritramid</intervention_name>
    <description>Piritramid will be administered i.v., if the patients feel pain after receiving a bolus of Ropivacaine or saline through the catheter.</description>
    <arm_group_label>Ropivacaine continous infusion</arm_group_label>
    <arm_group_label>Ropivacaine bolus</arm_group_label>
    <arm_group_label>Saline continous</arm_group_label>
    <other_name>Dipidolor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Ropivacaine continous infusion</arm_group_label>
    <arm_group_label>Ropivacaine bolus</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <arm_group_label>Saline continous</arm_group_label>
    <other_name>Saline Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients after minimally invasive aortic valve surgery

          -  Patients agreement with the study

        Exclusion Criteria:

          -  Age under 18 years

          -  Allergy to local anesthetic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maja Sostaric, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical department of anesthesiology and intensive care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maja Sostaric, PhD</last_name>
    <phone>+386 31 859462</phone>
    <email>maja.sos@siol.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Clinical Center Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maja Sostaric, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 8, 2017</lastchanged_date>
  <firstreceived_date>October 11, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Maja Sostaric</investigator_full_name>
    <investigator_title>asoc. prof.</investigator_title>
  </responsible_party>
  <keyword>aortic valve surgery</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Pirinitramide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
